Holen Sie sich die Stockscreener-App
178.48
0.96%
1.70
Schlusskurs vom Vortag:
$176.78
Offen:
$176.58
24-Stunden-Volumen:
134.52K
Relative Volume:
0.25
Marktkapitalisierung:
$11.39B
Einnahmen:
$13.84B
Nettoeinkommen (Verlust:
$1.10B
KGV:
17.13
EPS:
10.4185
Netto-Cashflow:
$1.49B
1W Leistung:
+1.21%
1M Leistung:
-0.88%
6M Leistung:
+20.24%
1J Leistung:
+39.56%
1-Tages-Spanne:
$175.41
$178.49
1-Wochen-Bereich:
$175.76
$182.60
52-Wochen-Spanne:
$101.00
$247.49
Davita Inc Stock (DVA) Company Profile
Firmenname
Davita Inc
Sektor
Branche
Telefon
310-536-2668
Adresse
2000 16TH STREET, DENVER, CO
Compare DVA vs HCA, THC, EHC, FMS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
178.48 | 11.39B | 13.84B | 1.10B | 1.49B | 10.42 |
HCA
Hca Healthcare Inc
|
443.12 | 95.94B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
262.25 | 21.12B | 21.46B | 2.65B | 3.35B | 19.23 |
EHC
Encompass Health Corp
|
122.81 | 12.12B | 6.07B | 793.80M | 464.40M | 5.9914 |
FMS
Fresenius Medical Care Ag Adr
|
20.70 | 11.02B | 22.44B | 1.35B | 2.03B | 1.9002 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-08-07 | Hochstufung | TD Cowen | Hold → Buy |
| 2026-05-06 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2023-08-07 | Hochstufung | UBS | Neutral → Buy |
| 2022-11-01 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-10-31 | Herabstufung | UBS | Buy → Neutral |
| 2022-08-19 | Fortgesetzt | UBS | Buy |
| 2022-06-21 | Bestätigt | BofA Securities | Underperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-08-12 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-03-26 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-01-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-01-24 | Hochstufung | Goldman | Neutral → Buy |
| 2019-11-07 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | Hochstufung | UBS | Sell → Neutral |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2018-12-14 | Eingeleitet | Barclays | Overweight |
| 2018-11-28 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | Eingeleitet | UBS | Sell |
| 2018-11-08 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2018-01-04 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-12-07 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-06-26 | Herabstufung | Jefferies | Buy → Hold |
| 2016-12-13 | Herabstufung | Robert W. Baird | Outperform → Neutral |
Alle ansehen
Davita Inc Aktie (DVA) Neueste Nachrichten
Strength Seen in Option Care (OPCH): Can Its 32.7% Jump Turn into More Strength? - Zacks Investment Research
DaVita stock enters October 23 report after Q2 earnings beat - AD HOC NEWS
DaVita Inc. (DVA) Stock Forecasts - Yahoo Finance
DaVita Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
DaVita HealthCare (DVA) Laps the Stock Market: Here's Why - Zacks Investment Research
DaVita HealthCare (DVA) Laps the Stock Market: Here's Why - Yahoo Finance
DaVita Inc. (DVA) Stock forecasts - Yahoo Finance UK
DaVita Inc. (DVA) Stock Forecasts - Yahoo Finance
DaVita Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Is DaVita Stock Underperforming the S&P 500? - webull.com
DaVita stock heads into the open after September 24 loss - AD HOC NEWS
DaVita Inc (DVA) Shares Fall 4.6% -- What GF Score of 92 Tells I - GuruFocus
DaVita HealthCare (DVA) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance
DaVita Inc. stock underperforms Thursday when compared to competitors - MarketWatch
DaVita Inc. (DVA) Stock Forecasts - Yahoo! Finance Canada
DaVita stock heads into the open after a 0.55 percent gain - AD HOC NEWS
Is DaVita Stock Underperforming the S&P 500? - Yahoo Finance
Is DaVita Stock Underperforming the S&P 500? - inkl
DaVita stock holds above USD 183 as earnings estimates rise - AD HOC NEWS
DaVita (NYSE:DVA) Stock Forecast & Analyst Predictions - Simply Wall Street
DaVita Inc. stock slips 0.65 percent as earnings support outlook - AD HOC NEWS
DaVita Inc. (DVA) Stock Analysis: Uncovering a 19.58% Upside Within the Healthcare Sector - DirectorsTalk Interviews
DaVita Inc (DVA) Shares Fall 5.6% -- What GF Score of 91 Tells I - GuruFocus
DaVita Inc. stock underperforms Thursday when compared to competitors - MarketWatch
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
DaVita HealthCare (DVA) Advances While Market Declines: Some Information for Investors - Yahoo Finance
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
DaVita Inc. stock advances as Q2 2026 earnings and guidance underpin strong valuation - ad-hoc-news.de
DaVita Community Care Report 2025: Our Journey to Net Zero - ACCESS Newswire
DaVita Community Care Report 2025: Our Journey to Net Zero - StreetInsider
DaVita Community Care Report 2025: Our Journey to Net Zero - Yahoo Finance
DaVita stock heads into the open after a 1.9% gain - ad-hoc-news.de
DaVita to pay $15M to settle data breach lawsuit - Tri-Cities Area Journal of Business
DaVita Inc. stock gains as guidance and earnings support strong 2026 outlook - ad-hoc-news.de
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
Here's Why You Should Retain DaVita Stock in Your Portfolio for Now - Yahoo Finance
DaVita stock heads into the open after a 0.9% gain - ad-hoc-news.de
DaVita Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
DaVita Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Commitment to Helping Communities Thrive: DaVita Community Care Report 2025 - StreetInsider
Commitment to Helping Communities Thrive: DaVita Community Care Report 2025 - accessnewswire.com
DaVita Inc. stock holds near recent highs on solid Q2 2026 earnings and guidance - ad-hoc-news.de
Commitment to Helping Communities Thrive: DaVita Community Care Report 2025 - Yahoo Finance
DaVita stock heads into the open after a flat prior close - ad-hoc-news.de
DaVita Inc. stock gains support from solid Q2 2026 earnings - ad-hoc-news.de
DaVita Inc. (DVA) Stock Analysis: Evaluating the 18.72% Upside Potential for Healthcare Investors - DirectorsTalk Interviews
DaVita Inc. stock gains on solid Q1 figures and buybacks - ad-hoc-news.de
DaVita $15M Data Breach Settlement Hits 2.4M Patients - tech-insider.org
DaVita stock gains as Humana expands kidney care - ad-hoc-news.de
Healthcare August recap: Moderna jumps 156% as biotech shines; DaVita sinks - Seeking Alpha
Finanzdaten der Davita Inc-Aktie (DVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Davita Inc-Aktie (DVA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Javier Rodgriguez | Officer |
Jun 16 '26 |
Proposed Sale |
209.28 |
39,407 |
8,247,016 |
0 |
| Rodriguez Javier | Chief Executive Officer |
Jun 16 '26 |
Sale |
209.28 |
39,407 |
8,247,018 |
840,408 |
| Kathleen Waters | Officer |
Jun 15 '26 |
Proposed Sale |
207.84 |
8,950 |
1,860,202 |
0 |
| Javier Rodriguez | Officer |
Jun 15 '26 |
Proposed Sale |
209.50 |
30,000 |
6,285,102 |
0 |
| Waters Kathleen Alyce | Officer |
Jun 15 '26 |
Proposed Sale |
207.93 |
6,455 |
1,342,188 |
0 |
| Waters Kathleen Alyce | Chief Legal & Pub. Affairs Off |
Jun 15 '26 |
Sale |
208.40 |
15,405 |
3,210,377 |
109,194 |
| Rodriguez Javier | Chief Executive Officer |
Jun 15 '26 |
Sale |
209.50 |
30,000 |
6,285,090 |
879,815 |
| HEARTY JAMES O | Chief Compliance Officer |
May 15 '26 |
Sale |
193.98 |
15,000 |
2,909,745 |
22,389 |
| James Hearty | Officer |
May 15 '26 |
Proposed Sale |
193.93 |
15,000 |
2,908,950 |
0 |
| HEARTY JAMES O | Chief Compliance Officer |
May 14 '26 |
Option Exercise |
110.63 |
5,784 |
639,884 |
41,737 |
0.07%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):